Recombinant Proteins
Modified or manipulated proteins encoded by recombinant DNA and suitable for a variety of purposes including the modification of gene sequences, mass protein production, and the manufacture of commercial products.
Recombinant
- (285)
- (11)
- (66,342)
- (1)
For Use With (Application)
- (2)
- (970)
- (1)
- (23,540)
- (5)
- (1)
- (1)
- (67)
- (370)
- (4,450)
- (23)
- (1)
- (4)
- (2)
- (13)
- (21,446)
- (3)
- (4)
- (3)
- (1)
- (2)
- (4)
- (14)
- (71)
- (2)
- (2)
- (2)
- (1)
- (3)
- (2)
- (1)
- (157)
- (3)
- (4)
- (1)
- (1)
- (1)
- (3)
- (253)
- (23,062)
- (1)
- (1)
- (2)
- (1)
- (13)
- (26,800)
- (406)
- (32)
- (3)
- (708)
- (14)
- (2)
- (1)
- (8)
- (1)
- (5)
- (1)
- (105)
- (1)
- (3,750)
- (1,407)
- (3)
- (4)
- (5)
- (1)
- (1)
- (1)
- (1)
- (14)
- (138)
- (48)
- (6)
- (17)
- (2)
- (1)
- (10)
- (4)
- (81)
- (12)
- (2)
- (3)
- (80)
- (4)
- (113)
- (96)
- (19)
- (1)
- (1)
- (4)
- (1)
- (1,522)
- (2)
- (1)
- (160)
- (18)
- (48)
- (3)
- (3)
- (1)
- (2)
- (9)
- (27)
- (2)
- (510)
- (1)
- (4)
- (1)
- (2)
- (114)
- (44)
- (2)
- (1)
- (1)
- (4)
- (1)
- (1)
- (3)
- (1)
- (23,708)
- (6)
- (3)
- (1)
- (1)
- (63)
- (6)
- (2)
- (7)
- (5)
- (1)
- (2)
- (1)
- (1)
- (6,758)
- (6)
- (4)
- (1)
- (3)
- (1)
- (3)
- (2)
- (13)
- (17)
- (1)
- (3)
- (3)
- (4)
- (27,095)
- (235)
- (1)
- (3)
Species
- (2)
- (1)
- (2)
- (1)
- (89)
- (559)
- (96)
- (2)
- (1)
- (1)
- (2)
- (1)
- (27)
- (1)
- (8)
- (15)
- (1)
- (72)
- (1)
- (1,303)
- (1)
- (3)
- (16)
- (1)
- (3)
- (1)
- (1)
- (1)
- (8)
- (1)
- (4)
- (1)
- (1)
- (29,092)
- (5)
- (22)
- (8)
- (4)
- (1,291)
- (2)
- (1)
- (1)
- (3)
- (1)
- (1)
- (8)
- (14)
- (32)
- (24)
- (1)
- (2)
- (16)
- (233)
- (9)
- (2)
- (5)
- (1)
- (2)
- (2)
- (2)
- (23)
- (5)
- (3)
- (3)
- (2)
- (14)
- (23,574)
- (1)
- (48)
Form
- (15)
- (1)
- (2)
- (45,210)
- (6,120)
- (245)
- (168)
- (56)
- (3,361)
Conjugate
- (7)
- (1)
- (3)
- (18)
- (2)
- (62)
- (1)
- (4)
- (2)
- (9)
- (60)
- (1)
- (2)
- (3)
- (1)
- (417)
- (1)
- (3)
- (2)
- (1)
- (1)
- (1)
- (3)
- (2)
- (3)
- (19)
- (7)
- (2)
- (2)
- (3)
- (45)
- (1)
- (1)
- (1)
- (2)
- (5)
- (1)
- (1)
- (1)
- (2)
- (8)
- (2)
- (3)
- (43,546)
- (1)
- (11)
Filtered Search Results
Products from some of our suppliers do not display in filtered search results. Please
clear all filters
to see these products.
Search Within Results
Keyword Search:
Clear All
10,216
–
10,230
of
121,316
results
10,216
R&D Systems™ Recombinant Human BMP-10 Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 12.2 kDa (monomer) |
| Gene ID (Entrez) | 27302 |
| Quantity | 25 μg |
| Structural Form | Disulfide-linked homodimer |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Chinese Hamster Ovary cell line,CHO-derived human BMP-10 protein Asn317-Arg424 |
| Recombinant | Recombinant |
| Name | BMP-10 |
10,217
R&D Systems™ Recombinant Human Thrombopoietin Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 97%, by SDS-PAGE with silver staining. |
|---|---|
| Conjugate | Unconjugated |
| Gene Alias | Megakaryocyte colony-stimulating factor, Megakaryocyte growth and development factor, megakaryocyte stimulating factor, MGDF, MGDFC-mpl ligand, MKCSF, MK-CSF, ML, MPL ligand, MPLLG, MPLLGMGC163194, Myeloproliferative leukemia virus oncogene ligand, THCYT1, THPO, thrombopoietin, thrombopoietin nirs variant 1, Tpo, TPOMKCSF |
| Molecular Weight (g/mol) | 35 kDa |
| Gene ID (Entrez) | 7066 |
| Source | Spodoptera frugiperda,Sf 21 (baculovirus)-derived human Thrombopoietin/Tpo protein Ser22-Gly353 |
| Recombinant | Recombinant |
| Name | Thrombopoietin/Tpo |
10,218
R&D Systems™ Recombinant Human Serpin E2/PN1 Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Inhibition Activity
10,219
| Regulatory Status | RUO |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions |
| Conjugate | Unconjugated |
| Form | Liquid |
| Formulation | Laemmli with no preservative; pH 6.8 |
| Sequence | Amino acids Glu208- Ile738 containing an N-terminal His-tag |
| Concentration | 0.05 mg/mL |
| For Use With (Application) | Control,Western Blot |
| Source | E. Coli |
| Name | Human ADAM12 S Isoform |
| Recombinant | Recombinant |
10,220
| Purity or Quality Grade | >90% by SDS-PAGE |
|---|---|
| Conjugate | Unconjugated |
| Form | Liquid |
| pH Range | 7.4 |
| Common Name | SARS-CoV-2 Spike Protein RBD |
| Sequence | SARS-CoV-2 Spike Protein RBD, full length (s-RBD region) with a His-tag |
| Storage Requirements | Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. |
| Concentration | 7.6 mg/mL |
| Expression System | Insect cells |
| For Use With (Application) | ELISA Standard,Binding Assay,Bioactivity |
| Name | SARS-CoV-2 Spike Protein (RBD) (aa319-541), His Tag |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | Coronavirus; COVID; Covid 19; COVID19; COVID-19; SARS; SARS Coronavirus; SARS CoV; SARS CoV2; SARS CoV-2; SARS Spike Protein; SARS-CoV2; SARS-CoV-2 |
| Product Type | Protein |
| Formulation | PBS with no preservative; pH 7.4 |
| Protein Tag | His-tag |
| Recombinant | Recombinant |
10,221
| Regulatory Status | RUO |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions |
| Conjugate | Unconjugated |
| Form | Liquid |
| Formulation | 0.025 M sodium acetate with 1 mM EDTA, 50% glycerol and no preservative; pH 4.8 |
| Sequence | Amino acids Ser82-Thr190 containing an N-terminal His-tag |
| Concentration | 0.11 mg/mL |
| For Use With (Application) | Control,Western Blot |
| Source | E. coli |
| Name | Human PDGF-B |
| Recombinant | Recombinant |
10,222
| Purity or Quality Grade | ≥97% |
|---|---|
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Molecular Weight (g/mol) | 15.5 kDa |
| Common Name | IL-2 |
| Gene Symbol | IL2 |
| Activity | ED50 ≤3 ng/mL; determined by the dose-dependent proliferation of CTLL-2 cells. |
| Endotoxin Concentration | ≤0.1 EU/μg |
| Storage Requirements | -20°C, Avoid Freeze/Thaw Cycles |
| Sequence | MAPTSSSTKK TQLQLEHLLL DLQMILNGIN NYKNPKLTRM LTFKFYMPKK ATELKHLQCL EEELKPLEEV LNLAQSKNFH LRPRDLISNI NVIVLELKGS ETTFMCEYAD ETATIVEFLN RWITFCQSII STLT. |
| Concentration | 0.1 mg/mL |
| Expression System | E. coli |
| For Use With (Application) | Control,Bioactivity |
| Name | Human IL-2 |
| Accession Number | P60568 |
| Regulatory Status | RUO |
| Purification Method | Purified |
| Gene Alias | aldesleukin; cytokine; H-IL-2; il 2; Il2; Il-2; ILN; Interleukin; interleukin 2; interleukin 2 precursor; interleukin 2 variant IL2delta2; Interleukin2; Interleukin-2; interleukin-2 precursor; interleukin-2 precursor protein; interleukin-2; interleukin 2; Involved in regulation of T cell clonal expansion; involved in regulation of T-cell clonal expansion; lymphokine; M-IL-2; patial sequence of Interleukin-2; POIL2; porcine Interleukin 2; T cell growth factor; T-cell growth factor; T-cell growth factor (TCGF); TCGF |
| Product Type | Protein |
| Gene ID (Entrez) | 3558 |
| Formulation | 0.1% TFA with no preservative |
| Recombinant | Recombinant |
10,223
R&D Systems™ Recombinant Mouse Sortilin Protein
Extensive quality control produces lot-to-lot consistency that instills confidence in results and ensures reproducibility.
10,224
R&D Systems™ Recombinant Mouse Mimecan Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
10,225
R&D Systems™ Recombinant Mouse Wnt-5b Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
| Purity or Quality Grade | 75%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
|---|---|
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | 38.6 kDa |
| Quantity | 25 μg |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. |
| Source | Chinese Hamster Ovary cell line,CHO-derived mouse Wnt-5b protein Gln31-Lys372 |
| Recombinant | Recombinant |
| Name | Wnt-5b |
10,226
| Regulatory Status | RUO |
|---|---|
| Purity or Quality Grade | >95%, by SDS-PAGE under reducing conditions |
| Conjugate | Unconjugated |
| Form | Liquid |
| Formulation | 20 mM tris HCl with 50% glycerol and no preservative; pH 8 |
| Sequence | Amino acids Met1- Leu241 containing an N-terminal His-tag |
| For Use With (Application) | Control,Western Blot |
| Source | E. coli |
| Name | Human GST Omega 1 140 A |
| Recombinant | Recombinant |
10,227
R&D Systems™ Recombinant Human Thrombopoietin (NS0-expressed) Protein
A new economical version of TPO made in E. coli is now available.
| Buffer | Lyophilized from a 0.2 μm filtered solution in PBS. |
|---|---|
| Purity or Quality Grade | >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
| Conjugate | Unconjugated |
| Molecular Weight (g/mol) | M.W. (Observed): 80-90 kDa, reducing conditions; M.W. (theoretical): 35 kDa |
| Endotoxin Level | <0.1 EU per 1 μg of the protein by the LAL method. |
| Gene Symbol | THPO |
| Endotoxin Concentration | <0.10 EU / 1 μg of the protein by the LAL method. |
| Storage Requirements | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution. |
| For Use With (Application) | Bioactivity |
| Protein | Thrombopoietin/THPO |
| Source | Mouse myeloma cell line, NS0-derived human Thrombopoietin/Tpo protein Ser22-Gly353 |
| Name | Megakaryocyte colony-stimulating factor, Megakaryocyte growth and development factor, megakaryocyte stimulating factor, MGDF, MGDFC-mpl ligand, MKCSF, MK-CSF, ML, MPL ligand, MPLLG, MPLLGMGC163194, Myeloproliferative leukemia virus oncogene ligand, THCYT1, THPO, thrombopoietin, thrombopoietin nirs variant 1, Tpo, TPOMKCSF |
| Accession Number | P40225 |
| Gene ID (Entrez) | 7066 |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Reconstitution | Reconstitute at 100 μg/mL in sterile PBS. |
| Species | Human |
10,228
Promotions Available
R&D Systems™ Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera Protein
![]()
R&D Systems™ Recombinant Human LILRB1/CD85j/ILT2 Fc Chimera Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
